COMPASS Pathways Plc American Depository Shares (CMPS) Stock
Fundamentals
Source: third-party data provider, as of October 12, 2026
Compare with CMPS
Recent news

Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms
Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms
CMPS

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CMPS

Compass Pathways Appoints Kelley Boucher as Chief People Officer
Compass Pathways Appoints Kelley Boucher as Chief People Officer
CMPS

Compass Pathways Targets Q4 COMP360 NDA Completion, Eyes 2027 Launch
Compass Pathways Targets Q4 COMP360 NDA Completion, Eyes 2027 Launch
CMPS
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 40.15
- MACD 12/26/9
- -0.59
- EMA 9 of MACD
- -0.40
- MACD histogram
- -0.19
- SMA 50
- $13.41
- Price below SMA 50
- EMA 50
- $13.01
- Price below EMA 50
- SMA 200
- $10.06
- Price above SMA 200
- EMA 200
- $10.24
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 9, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 5 analysts
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms
Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms
CMPS

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CMPS

Compass Pathways Appoints Kelley Boucher as Chief People Officer
Compass Pathways Appoints Kelley Boucher as Chief People Officer
CMPS

Compass Pathways Targets Q4 COMP360 NDA Completion, Eyes 2027 Launch
Compass Pathways Targets Q4 COMP360 NDA Completion, Eyes 2027 Launch
CMPS

Compass Pathways Targets 2027 COMP360 Launch After Positive Phase III Depression Data
Compass Pathways Targets 2027 COMP360 Launch After Positive Phase III Depression Data
CMPS

Compass Pathways Eyes 2027 COMP360 Launch as FDA Review Advances
Compass Pathways Eyes 2027 COMP360 Launch as FDA Review Advances
CMPS

Compass Pathways Eyes 2027 COMP360 Launch as FDA Filing Nears
Compass Pathways Eyes 2027 COMP360 Launch as FDA Filing Nears
CMPS

Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026
Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026
CMPS

Compass Pathways Launches ‘Change the Tune in TRD' in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026
Compass Pathways Launches ‘Change the Tune in TRD' in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026
CMPS

Strata Mental Health Solutions Awarded U.S. Healthcare Provider Training Grant from Compass Pathways to Develop Provider Training for COMP360
Strata Mental Health Solutions Awarded U.S. Healthcare Provider Training Grant from Compass Pathways to Develop Provider Training for COMP360
CMPS
News tone: automated (AI) classification of the article's content, not a price prediction.
About COMPASS Pathways Plc American Depository Shares
No description available.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Kabir Kumar Nath M.A., M.B.A. | CEO & Executive Director | 1964 |
| Ms. Teri Loxam M.B.A. | Chief Financial Officer | 1973 |
| Dr. Guy Goodwin | Chief Medical Officer | 1948 |
| Mr. Stephen D. Schultz | Senior Vice President of Investor Relations | — |
| Mr. Lars Christian Wilde | Senior Advisor | 1986 |
| Dr. Susan C. Stansfield Ph.D. | Advisor | — |
| Dr. Michael Gold M.D., M.Sc. | Chief Research & Development Officer | 1961 |
| Ms. Lori Englebert M.B.A. | Chief Commercial Officer | 1978 |
| Dr. Steve Levine M.D. | Chief Patient Officer | — |
| Mr. Benjamin Harber | Company Secretary | 1977 |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Source: third-party data provider, as of October 12, 2026
Technical indicators
- RSI 14
- 40.15
- MACD 12/26/9
- -0.59
- EMA 9 of MACD
- -0.40
- MACD histogram
- -0.19
- SMA 50
- $13.41
- Price below SMA 50
- EMA 50
- $13.01
- Price below EMA 50
- SMA 200
- $10.06
- Price above SMA 200
- EMA 200
- $10.24
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 9, 2026. Technical data, not a recommendation.
Analyst views
5 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $13.00
- Average
- $27.80
- High
- $65.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +33.7 | -22.9 | -30.9 | |||||||||
| 2022 | -31.6 | -12.3 | -11.8 | -32.2 | -7.2 | +27.6 | +44.4 | +9.4 | -33.4 | -1.9 | -3.3 | -21.4 |
| 2023 | +34.5 | -22.2 | +22.1 | -19.0 | -9.2 | +9.1 | +9.8 | +1.1 | -20.7 | -16.6 | +3.5 | +43.4 |
| 2024 | +25.4 | -9.4 | -27.5 | -11.5 | -13.0 | -20.5 | +28.2 | +8.7 | -12.9 | -20.1 | -3.2 | -15.8 |
| 2025 | +3.9 | -8.8 | -22.1 | +42.7 | +1.5 | -35.9 | +37.7 | +1.8 | +26.8 | +9.5 | -6.7 | +31.7 |
| 2026 | +2.1 | +4.4 | -21.2 | +61.2 | +45.0 | -0.3 | -14.6 | +20.1 | -6.0 | +0.4 |



